APA (7th ed.) Citation

Faber, R., Zander, M., Pena, A., Michelsen, M. M., Mygind, N. D., & Prescott, E. (2015). Effect of the glucagon-like peptide-1 analogue liraglutide on coronary microvascular function in patients with type 2 diabetes - a randomized, single-blinded, cross-over pilot study. Cardiovascular Diabetology, 14(1), 1. https://doi.org/10.1186/s12933-015-0206-3

Chicago Style (17th ed.) Citation

Faber, Rebekka, Mette Zander, Adam Pena, Marie M. Michelsen, Naja D. Mygind, and Eva Prescott. "Effect of the Glucagon-like Peptide-1 Analogue Liraglutide on Coronary Microvascular Function in Patients with Type 2 Diabetes - a Randomized, Single-blinded, Cross-over Pilot Study." Cardiovascular Diabetology 14, no. 1 (2015): 1. https://doi.org/10.1186/s12933-015-0206-3.

MLA (9th ed.) Citation

Faber, Rebekka, et al. "Effect of the Glucagon-like Peptide-1 Analogue Liraglutide on Coronary Microvascular Function in Patients with Type 2 Diabetes - a Randomized, Single-blinded, Cross-over Pilot Study." Cardiovascular Diabetology, vol. 14, no. 1, 2015, p. 1, https://doi.org/10.1186/s12933-015-0206-3.